OSU CCTS: Then + Now

The present, past, and future of the Ohio State University Center for Clinical and Translational Science

In 2006, The Ohio State University Board of Trustees voted to create a new entity, The Ohio State University Center for Clinical and Translational Science, to speed the translation of scientific discoveries into clinical therapies to improve human health. Dr. Rebecca Jackson, MD, was named to lead the new enterprise based on her international recognition and outstanding leadership of numerous multicenter research collaborations. Her first task was to develop the application for a National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) grant to fund the new endeavor.

In 2008, the NIH awarded a $34-million, five-year CTSA grant to The Ohio State University – along with Nationwide Children’s Hospital – to fund the CCTS. Among the largest research grants in the University’s history, the CTSA award was a team effort based on the clinical and translational research enterprise, training programs, informatics capabilities, trans-disciplinary collaborations, and partnerships with private and public organizations.

In 2013, the NIH renewed the CTSA grant to The Ohio State University for a second five-year funding cycle with Nationwide Children’s Hospital continuing as the pediatric institutional partner.  CTSA funding via a U54 specialized center, TL1 trainee program, and KL2 scholar program is combined with significant local resources to provide for core resources, essential mentoring and training, and opportunities to develop innovative approaches and technologies designed to re-engineer existing capabilities. Program support also fosters collaborations to improve the quality, safety, efficiency and speed of clinical and translational research.  

Vision, Mission and Strategic Goals

Synergizing strengths and leveraging resources to catalyze scientific innovation….Turning the scientific discoveries of today into life-changing disease prevention strategies and the health diagnostics and treatments of tomorrow.

  • Vision: Catalyze research teams and facilitate innovation through the creation of an environment that fosters translation of knowledge to improve human health.
     
  • Mission: Transform and advance the discipline of clinical and translational science at The Ohio State University
     
  • Strategic goals:
    • Build on the unique and diverse strength of our institution to create an integrated academic home for innovative, team-oriented clinical and translational science.
    • Enhance and nurture the career development of highly trained investigators with an emphasis on innovation and transdisciplinary science.
    • Optimize the efficient conduct of the highest quality, generalizable clinical and translational science that is relevant to the community setting.
    • Develop, enhance and integrate a portfolio of outstanding shared resources
       
  • Core values: Innovation, Collaboration, Integration, Transformation, Enabling through Education, Sustain